The chemokine, macrophage inflammatory protein-2γ, reduces the expression of glutamate transporter-1 on astrocytes and increases neuronal sensitivity to glutamate excitotoxicity.

["Fang J", "Han D", "Hong J", "Tan Q", "Tian Y"]
Journal of neuroinflammation 2012
Open on PubMed

BACKGROUND: Changes in glutamatergic neurotransmission via decreased glutamate transporter (GLT) activity or expression contributes to multiple neurological disorders. Chemokines and their receptors are involved in neurological diseases but the role of chemokines in the expression of glutamate transporters is unclear. METHODS: Primary astrocytes were prepared from neonatal (<24 hours old) SJL/J mouse brains and incubated with 5 μg/ml lipopolysaccharide (LPS) or 50 ng/ml tumor necrosis factor α (TNF-α) for 24 hours. Soluble macrophage inflammatory protein-2γ (MIP-2γ) in culture supernatants was determined using a sandwich ELISA. The MIP-2γ effect on the expression of GLT-1 was measured by quantitative RT-PCR, flow cytometric analysis or western blot assay. Detergent-resistant membranes from astrocytes were isolated on the basis of their ability to float in density gradients. Raft-containing fractions were tracked by the enrichment of caveolin-1 and the dendritic lipid raft marker, flotillin-1. Cell viability was determined by measuring either the leakage of lactate dehydrogenase or the reduction of 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide by viable cells and confirmed by visual inspection. RESULTS: The production of the chemokine MIP-2γ by mouse cortical astrocytes increased significantly after stimulation with LPS or TNF-α in vitro. Astrocytes over-expressing MIP-2γ down-regulated the expression of GLT-1 at the mRNA and protein level and caused redistribution of GLT-1 out of the lipid rafts that mediate glutamate uptake. We used pharmacological inhibitors to identify the downstream signaling pathways underlying MIP-2γ activity. We also found complementary results by knocking down MIP-2γ activity in astrocytes with MIP-2γ small interfering RNA (siRNA). MIP-2γ overexpression in astrocytes enhanced the neuronal toxicity of glutamate by decreasing GLT-1 activity, but MIP-2γ itself was not toxic to neurons. CONCLUSIONS: These results suggest that MIP-2γ mediates the pathogenesis of central nervous system disorders associated with neutrophil infiltration in the brain and decreased GLT-1 activity.

7 Figures Extracted
Figure 1
Figure 1 PMC
Relative MIP-2γ mRNA and protein expression in astrocytes. ( a ) RT-PCR analysis of MIP-2γ expression in purified primary astrocyte cultures. Levels ...
Figure 2
Figure 2 PMC
Specific knockdown of MIP-2γ expression in cultured astrocytes by siRNA. Representative western blots of MIP-2γ and GFAP. The expression of MIP-2γ wa...
Figure 3
Figure 3 PMC
GLT-1 expression is down-regulated by MIP-2γ in primary cortical astrocytes. ( a ) Levels of GLT-1 mRNA were decreased in primary astrocytes transfec...
Figure 4
Figure 4 PMC
Overexpression of MIP-2γ inhibits GLT-1 expression in lipid rafts and increases caveolin-1 expression. Equal amounts of proteins from collected fract...
Figure 5
Figure 5 PMC
Effects of MIP-2γ overexpression on astrocyte glutamate uptake. Results are expressed as the ratio of [ 3 H]glutamate uptake of transfected cultures ...
Figure 6
Figure 6 PMC
Effect of pharmacological inhibitors on GLT-1 mRNA and protein expression. GLT-1 mRNA ( a ) and protein ( b ) expression in astrocytes either untreat...
Figure 7
Figure 7 PMC
Over-expression of MIP - 2γ makes neurons more sensitive to glutamate toxicity. Cortical astrocytes left untreated (control) or transfected with the ...